Morgan Stanley Nexalin Technology, Inc. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 59,805 shares of NXL stock, worth $252,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,805

Holding current value

$252,377

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.61 - $2.96 $36,481 - $177,022	59,805 New	59,805 $101,000
Q1 2023 May 15, 2023	SELL	$0.75 - $1.22 $588 - $957	-785 Reduced 38.41%	1,259 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.74 - $2.39 $1,512 - $4,885	2,044 New	2,044 $1,000

Others Institutions Holding NXL

# of Institutions

Shares Held

403K

Call Options Held

Put Options Held

Jim Simons Renaissance Technologies LLC | New York, Ny

103K
Shares

$434,238
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

78.7K
Shares

$332,101
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

55.5K
Shares

$234,049
0.81% of portfolio
Vanguard Group Inc Valley Forge, PA

31.8K
Shares

$134,111
0.0% of portfolio
Two Sigma Securities, LLC New York, NY

23K
Shares

$97,249
0.0% of portfolio

View Full List

About Nexalin Technology, Inc.

Ticker NXL
Exchange
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,279,960
Market Cap $30.7M

More about NXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account